Augmont Enterprises IPO Day 3: GMP ₹300 (+₹20)

Welcome back, investors! It’s Day 3 of the Augmont Enterprises IPO subscription, and we’re diving deep into the numbers to see how this mainboard offering on the NSE is shaping up. With the IPO period running from August 21st to August 25th, 2026, and an issue price of ₹788 per share, today’s update is crucial for anyone considering an investment. Let’s get straight to it.

Subscription Status

As of Day 3, the subscription numbers for Augmont Enterprises IPO are showing a solid 0x across all categories – Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). While this might initially sound like a lack of activity, it’s important to understand what this actually means. Often, towards the beginning and middle of the subscription period, especially for mainboard IPOs with a higher issue price like Augmont’s at ₹788, substantial booking happens towards the fag end. Retail investors, in particular, tend to wait for the last couple of days to gauge overall sentiment and GMP trends. The absence of early, massive oversubscription in NII and QIB segments isn’t necessarily a red flag at this stage. It suggests a more measured approach from these sophisticated investors. However, we’ll be keeping a very close eye on how these numbers evolve over the remaining days. The total subscription standing at 0x means the market is still waiting to see the demand materialize.

GMP Update

Now, let’s talk about the Grey Market Premium (GMP). This is where things get interesting. The current GMP for Augmont Enterprises IPO stands at a robust ₹300. This is a significant jump from yesterday’s GMP of ₹280, marking an increase of ₹20. This upward movement is indeed encouraging. A rising GMP often reflects increased investor confidence and demand in the unofficial market, which can sometimes be a precursor to strong listing performance. Based on the current GMP of ₹300 and the issue price of ₹788, the expected listing price is around ₹1088 (₹788 + ₹300). This potential listing gain of approximately 38% is quite attractive and could be a major draw for many investors. The increase in GMP, despite the subscription numbers not yet showing explosive growth, suggests that the market is anticipating strong demand in the latter half of the subscription period.

Should You Apply?

So, the million-dollar question: should you be applying for the Augmont Enterprises IPO? It’s a balanced picture right now. On one hand, the subscription numbers are yet to show significant traction, which might make some cautious. However, the steadily increasing GMP is a very positive sign, indicating strong market sentiment and a potential for a healthy listing. The projected listing price of ₹1088 offers a compelling return. It’s also worth remembering that Augmont Enterprises is a mainboard IPO, which generally attracts a different caliber of investor compared to SME listings. For those new to IPO investing, SEBI’s advisor guidelines often suggest looking at a combination of company fundamentals, subscription levels, and GMP trends. Given the current GMP, it seems like a reasonable bet, but it’s always wise to do your own due diligence. The lot size is 19 shares, so factor that into your investment calculations. The bottom line is, if the GMP continues to hold or rise, and subscription numbers pick up in the final days, this could be a good opportunity. Don’t miss out on more detailed information and analysis.

View Full Augmont Enterprises IPO Details